Ladd Amy L 4

Accession 0001035267-25-000137

CIK 0001035267other

View on SEC.gov Company Profile

Filed

Apr 30, 8:00 PM ET

Accepted

May 1, 8:24 PM ET

Size

31.0 KB

Accession

0001035267-25-000137

Insider Transaction Report

Form 4

Period: 2025-04-30

INTUITIVE SURGICAL INCISRG

Ladd Amy L

Director

Transactions

Sale
Common Stock
2025-04-30$505.55/sh−1,671$844,767→ 1,410 total
Sale
Common Stock
2025-04-30$505.55/sh−2,298$1,161,744→ 1,410 total
Sale
Common Stock
2025-04-30$505.55/sh−1,709$863,978→ 1,410 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-04-30−1,448→ 0 total
Exercise: $243.26Exp: 2029-04-27→ Common Stock (1,448 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-04-30−1,671→ 0 total
Exercise: $286.55Exp: 2031-04-22→ Common Stock (1,671 underlying)
Exercise/Conversion
Common Stock
2025-04-30$286.55/sh+1,671$478,831→ 3,081 total
Exercise/Conversion
Common Stock
2025-04-30$171.07/sh+2,298$393,126→ 3,708 total
Exercise/Conversion
Common Stock
2025-04-30$243.26/sh+1,448$352,240→ 2,858 total
Sale
Common Stock
2025-04-30$505.55/sh−1,448$732,030→ 1,410 total
Exercise/Conversion
Common Stock
2025-04-30$171.20/sh+1,650$282,480→ 3,060 total
Sale
Common Stock
2025-04-30$505.55/sh−1,650$834,151→ 1,410 total
Exercise/Conversion
Common Stock
2025-04-30$295.92/sh+1,709$505,727→ 3,119 total
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-04-30−2,298→ 0 total
Exercise: $171.07Exp: 2030-04-23→ Common Stock (2,298 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-04-30−1,650→ 0 total
Exercise: $171.20Exp: 2029-08-02→ Common Stock (1,650 underlying)
Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-04-30−1,709→ 0 total
Exercise: $295.92Exp: 2030-04-26→ Common Stock (1,709 underlying)
Award
Restricted Stock Units
2025-05-01+531→ 531 total
Exercise: $0.00→ Common Stock (531 underlying)

Footnotes (4)

[F1]The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on January 29, 2026.
[F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $502.49 to $509.99 as follows: 1,758 shares sold at $502.49 to $503.39; 1,542 shares sold at $503.81 to $504.79; 1,951 shares sold at $504.83 to $505.77; 1,845 shares sold at $505.88 to $506.53; 610 shares sold at $506.90 to $507.84; and 1,070 shares sold at $509.99. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
[F3]100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer.
[F4]100% of the RSUs shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

INTUITIVE SURGICAL INC

CIK 0001035267

→

Entity typeother

Related Parties

filerCIK 0001781750

Filing Metadata

Form type: 4
Filed: Apr 30, 8:00 PM ET
Accepted: May 1, 8:24 PM ET
Size: 31.0 KB

View on SEC.gov